Colony Group’s Redhill Biopharma RDHL Stock Holding History

Colony Group’s Portfolio RDHL Stock Details RDHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-32	Closed	-$327K	–	757
2020 Q3	$327K	Buy	+32	New	+$262K	0.01%	562

Other funds holding RDHL

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Colony Group's RDHL Position: Q4 2020 in Review

Colony Group sold out of Redhill Biopharma (RDHL) in Q4 2020, closing a stake of 32 shares — an estimated $327K sold.

Colony Group first reported a position in RDHL in Q3 2020 and held it in 1 quarter. The position peaked at $327K in Q3 2020. 52 funds tracked by Wall St. Rank hold RDHL as of Q4 2020.

Colony Group reported no remaining Redhill Biopharma position as of Q4 2020 after selling out during the quarter.
Colony Group sold 32 Redhill Biopharma shares in Q4 2020, an estimated $327K.
Colony Group first reported a position in Redhill Biopharma in Q3 2020 and held it in 1 quarter.
Colony Group's Redhill Biopharma position peaked at $327K in Q3 2020.
52 funds tracked by Wall St. Rank held Redhill Biopharma as of Q4 2020.

Based on Colony Group's 13F filing for Q4 2020, filed 16 Feb 2021.